ALEXIS HOBBINS-WHITE

As a Director, Operational Strategy with over 17 years’ experience from the Pharma, Biotech and CRO side of clinical trial planning, execution and leadership, Alexis uses her expertise to support Precision for Medicine (PFM) clients. This includes the development of study and portfolio level strategies. Alexis has managed global studies from Phase I FIH to logistically complex Phase III studies and has a passion for operational excellence, process management and study finance. Alexis holds a degree in Neuroscience and a Masters in Biotechnology Law and Ethics. With a focus in Oncology and Rare Disease, PFM is now also supporting clients within Neurology, CVS and Pediatric indications.